PECATI: A Multicentric, Open-Label, Single-Arm Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab and Lenvatinib in Pretreated B3-Thymoma and Thymic Carcinoma Patients
Author:
Funder
Merck Sharp and Dohme
Publisher
Elsevier BV
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference19 articles.
1. The 2015 World Health Organization classification of tumors of the thymus: continuity and changes;Marx;J Thorac Oncol,2015
2. The impact of thymoma histotype on prognosis in a worldwide database;Weis;J Thorac Oncol,2015
3. Autoimmune diseases in centrally reviewed thymic epithelial tumours (TET);Montanez;Ann Oncol,2020
4. A phase II study of pemetrexed in patients with recurrent thymoma and thymic carcinoma;Gbolahan;J Thorac Oncol,2018
5. Phase II study of everolimus in patients with thymoma and thymic carcinoma previously treated with cisplatin-based chemotherapy;Zucali;J Clin Oncol,2018
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A Phase 1/2 Study to Evaluate the Safety and Activity of Nivolumab in Combination With Vorolanib, a Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor, in Patients With Refractory Thoracic Tumors;JTO Clinical and Research Reports;2024-02
2. Progress in the treatment of malignant ascites;Critical Reviews in Oncology/Hematology;2024-02
3. The Molecular Landscape of Thymic Epithelial Tumors: A Comprehensive Review;International Journal of Molecular Sciences;2024-01-26
4. What Have We Learned from Molecularly Informed Clinical Trials on Thymomas and Thymic Carcinomas—Current Status and Future Directions?;Cancers;2024-01-18
5. Diagnosis, combined treatment, and long-term follow-up of a thymoma patient;PULMONOLOGIYA;2023-12-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3